SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-355531
Filing Date
2012-08-14
Accepted
2012-08-14 16:05:46
Documents
13
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d355639d10q.htm 10-Q 456559
2 EX-10.1 d355639dex101.htm EX-10.1 9932
3 EX-31.1 d355639dex311.htm EX-31.1 6006
4 EX-31.2 d355639dex312.htm EX-31.2 6036
5 EX-32.1 d355639dex321.htm EX-32.1 4040
12 GRAPHIC g355639002.jpg GRAPHIC 2139
13 GRAPHIC g355639g78h31.jpg GRAPHIC 4752
  Complete submission text file 0001193125-12-355531.txt   4533459

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rxii-20120630.xml EX-101.INS 538594
7 XBRL TAXONOMY EXTENSION SCHEMA rxii-20120630.xsd EX-101.SCH 59291
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20120630_cal.xml EX-101.CAL 62153
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20120630_def.xml EX-101.DEF 68585
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20120630_lab.xml EX-101.LAB 394931
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20120630_pre.xml EX-101.PRE 246300
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 121032822
SIC: 2834 Pharmaceutical Preparations